• Act II Global Acquisition Corp. (NASDAQ: ACTT), a special purpose acquisition company, in connection with its US$426 million business combination with Merisant Company and MAFCO Worldwide LLC, each business lines from a subsidiary of MacAndrews & Forbes Incorporated
  • Credible Labs Inc. (ASX: CRD), an online financial technology company, in connection with its US$265 million acquisition by Fox Corp. (NASDAQ: FOX), a global media company
  • Orgenesis Inc. (NASDAQ: ORGS), a global biotechnology company that focuses on the development, manufacturing and provision of cell and gene therapies, in connection with its US$19 million acquisition of the assets of Tamir Biotechnology, Inc., a clinical stage anti-viral therapeutics company, including its lead asset, ranpirnase
  • Vermont Systems, Inc., a market leader in recreation management software for public entities, in connection with its sale of all outstanding equity interest to Clubessential Holdings, LLC, a leading provider of membership and club management solutions for the private club, college athletic, and health and fitness markets
  • ACT II Global Acquisition Corp. (NASDAQ: ACTT), a special purpose acquisition company, in connection with its proposed US$75 million private placement to a consortium of investors led by Baron Small Cap Funds
  • CS Technology, Inc. in its investment in the Series B preferred stock financing of Sitehands, Inc., led by FTV Management Company, L.P.